SCHEMBL24601535

SCHEMBL24601535

Cc1cc(C)c(-c2cccc3c4c5c6cccc(-c7c(C)cc(C)cc7C)c6n6c7c(-c8c(C)cc(C)cc8C)cccc7c(c7c8cccc(-c9c(C)cc(C)cc9C)c8n(c23)c47)c56)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.40
CYP2A6 P11509 2/20 0.40
CRHR1 P34998 6/20 0.39
KDM4E B2RXH2 3/20 0.34
HPGD P15428 2/20 0.34
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
KMT2A Q03164 1/20 0.33
KEAP1 Q14145 1/20 0.33
NFE2L2 Q16236 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDK2 Q15119 1/20 0.33
BRD1 O95696 1/20 0.32
TAF1 P21675 1/20 0.32
BRPF1 P55201 1/20 0.32
CYP1B1 Q16678 1/20 0.30
MAPT P10636 1/20 0.30
PABPC1 P11940 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
RAPGEF4 Q8WZA2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601592 0.79 CYP1A2 (0.38) CYP1A2CYP2A6CRHR1KDM4EHPGD
SCHEMBL24601775 0.78 CHEK1 (0.32) CYP1A2CYP2A6
SCHEMBL24601438 0.77 ALKBH5 (0.41) CYP1A2CYP2A6KDM4EMEN1KMT2A
SCHEMBL24601506 0.75 FLT3 (0.35) CYP1A2CYP2A6CRHR1KDM4EMAPT
SCHEMBL24601480 0.74 FLT3 (0.34) CYP1A2CYP2A6CRHR1KDM4EMAPT
SCHEMBL15673166 0.71 PABPC1 (0.50) CYP1A2CYP2A6CRHR1KDM4EHPGD
SCHEMBL27404519 0.71 RAPGEF4 (0.40) CYP1A2CYP2A6CRHR1KDM4EMEN1
SCHEMBL2453274 0.71 CYP1A2 (0.41) CYP1A2CYP2A6CRHR1KDM4EHPGD
SCHEMBL20609436 0.71 CYP2A6 (0.55) CYP1A2CYP2A6CRHR1KDM4EHPGD
SCHEMBL29444802 0.71 CYP1A2 (0.41) CYP1A2CYP2A6CRHR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 CYP1A2 4681/4885CYP2A6 4829/4885CRHR1 4389/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.